1 - 10 out of 75Page size: 10
  1. 2023

  2. A natural history study of paediatric non-alcoholic fatty liver disease over 10 years

    Draijer, L., Voorhoeve, M., Troelstra, M., Holleboom, A., Beuers, U., Kusters, M., Nederveen, A., Benninga, M. & Koot, B., 1 May 2023, In: JHEP Reports. 5, 5, 100685.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Machine learning algorithm improves detection of NASH (NAS-based) and at-risk NASH, a development and validation study

    LITMUS Investigators, 31 Mar 2023, (E-pub ahead of print) In: Hepatology (Baltimore, Md.).

    Research output: Contribution to journal › Article › Academic › peer-review

  4. Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study

    Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS) consortium investigators, 20 Mar 2023, (E-pub ahead of print) In: lancet. Gastroenterology & hepatology.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease

    van Son, K. C., Verschuren, L., Hanemaaijer, R., Reeves, H., Takkenberg, R. B., Drenth, J. P. H., Tushuizen, M. E. & Holleboom, A. G., 1 Feb 2023, In: Cancers. 15, 4, 1308.

    Research output: Contribution to journal › Review article › Academic › peer-review

  6. 2022

  7. Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis

    Houttu, V., Bouts, J., Vali, Y., Daams, J., Grefhorst, A., Nieuwdorp, M. & Holleboom, A. G., 3 Nov 2022, In: Frontiers in endocrinology. 13, 1032164.

    Research output: Contribution to journal › Review article › Academic › peer-review

  8. Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for nonalcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar

    Grobbee, E. J., de Jong, V. D., Schrieks, I. C., Tushuizen, M. E., Holleboom, A. G., Tardif, J-C., Lincoff, A. M., Schwartz, G. G., Cabezas, M. C. & Grobbee, D. E., 1 Nov 2022, In: PLoS ONE. 17, 11 November, e0277706.

    Research output: Contribution to journal › Article › Academic › peer-review

  9. Microbiome-derived ethanol in nonalcoholic fatty liver disease

    Meijnikman, A. S., Davids, M., Herrema, H., Aydin, O., Tremaroli, V., Rios-Morales, M., Levels, H., Bruin, S., de Brauw, M., Verheij, J., Kemper, M., Holleboom, A. G., Tushuizen, M. E., Schwartz, T. W., Nielsen, J., Brandjes, D., Dirinck, E., Weyler, J., Verrijken, A., de Block, C. E. M., & 7 othersVonghia, L., Francque, S., Beuers, U., Gerdes, V. E. A., Bäckhed, F., Groen, A. K. & Nieuwdorp, M., 1 Oct 2022, In: Nature medicine. 28, 10, p. 2100-2106 7 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  10. Self-supervised neural network improves tri-exponential intravoxel incoherent motion model fitting compared to least-squares fitting in non-alcoholic fatty liver disease

    Troelstra, M. A., van Dijk, A-M., Witjes, J. J., Mak, A. L., Zwirs, D., Runge, J. H., Verheij, J., Beuers, U. H., Nieuwdorp, M., Holleboom, A. G., Nederveen, A. J. & Gurney-Champion, O. J., 6 Sept 2022, In: Frontiers in physiology. 13, 942495.

    Research output: Contribution to journal › Article › Academic › peer-review

  11. Evaluation of nonalcoholic fatty liver disease (NAFLD) in severe obesity using noninvasive tests and imaging techniques

    Theel, W., Boxma-de Klerk, B. M., Dirksmeier-Harinck, F., van Rossum, E. F. C., Kanhai, D. A., Apers, J., van Dalen, B. M., de Knegt, R. J., Holleboom, A. G., Tushuizen, M. E., Grobbee, D. E., Wiebolt, J. & Castro Cabezas, M., Aug 2022, In: Obesity reviews. 23, 8, e13481.

    Research output: Contribution to journal › Review article › Academic › peer-review

  12. Clinicians’ Perspectives on Barriers and Facilitators for the Adoption of Non-Invasive Liver Tests for NAFLD: A Mixed-Method Study

    LITMUS Investigators, 1 May 2022, In: Journal of clinical medicine. 11, 10, 2707.

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1 2 3 4 5 6 7 8 Next

ID: 5136148